Key result
Septal embolization with Onyx reduces resting LVOT gradient by ~23 mm Hg with marked symptom relief.
Why the study?
Concerns regarding alcohol cardiotoxicity, arrhythmias, and pacemaker requirements following alcohol septal ablation prompted exploration of safer percutaneous alternatives for hypertrophic obstructive cardiomyopathy.
Does septal embolization using Onyx improve hemodynamics and symptoms in patients with hypertrophic obstructive cardiomyopathy?
Case Report (n=1)
No
Does septal embolization using Onyx improve hemodynamics and symptoms in patients with hypertrophic obstructive cardiomyopathy?
Septal embolization using Onyx appears to be a feasible, safe, and effective nonalcoholic alternative to alcohol septal ablation for reducing outflow tract obstruction and improving symptoms in select HOCM patients.
May support Onyx embolization in select HOCM cases; hypothesis-generating and should not change practice.
BACKGROUND: Hypertrophic obstructive cardiomyopathy (HOCM) is a genetic cardiac disorder characterized by left ventricular outflow tract obstruction due to septal hypertrophy and mitral regurgitation. When medical therapy is insufficient, invasive strategies such as surgical myectomy or percutaneous septal ablation are considered. Alcohol septal ablation is the most common percutaneous option for patients unfit for surgery. However, concerns about the cardiotoxicity of alcohol, the risk of arrhythmias, and pacemaker have prompted exploration of safer alternatives. CASE SUMMARY: We report the case of a 71-year-old woman with symptomatic HOCM who underwent septal embolization using Onyx, a nonalcoholic embolic agent. The patient experienced significant symptomatic and hemodynamic improvement, sustained over 12 months. DISCUSSION: Although alcohol septal ablation remains the standard percutaneous option, Onyx provided targeted septal infarction under fluoroscopic guidance without alcohol-related toxicity. TAKE-HOME MESSAGE: Onyx may be a promising and safe alternative for septal reduction in selected HOCM patients.
No takes yet. Share an insight, caveat, or question.
Torres et al. (2025) conducted a case report in Hypertrophic obstructive cardiomyopathy (n=1). Onyx (ethylene vinyl alcohol copolymer) septal embolization was evaluated on Symptomatic and hemodynamic improvement (LVOT gradient and NYHA class). Septal embolization using Onyx successfully reduced the resting left ventricular outflow tract gradient from 30 mm Hg to 7 mm Hg and improved symptoms from NYHA class III to I at 12 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: